HOWL

Companies
NASDAQ
Werewolf Therapeutics Inc.
Health Care
Price Chart
Overview

About HOWL

we are an immuno-oncology company advancing a pipeline of next generation, transformative cancer treatments.

Market Cap
$151.7M
Volume
991.7K
Avg. Volume
517.4K
P/E Ratio
-0.6263736
Dividend Yield
0.00%
Employees
45.0

Company Information

Exchange
NASDAQ
Sector
Health Care
Industry
Biotechnology
Risk & Correlation Analysis
Market Correlation
0.77
Moderate Correlation
Volatility
High (0.98)
Relative to market

Macro Factor Sensitivities

Interest Rates
Low Sensitivity
Inflation
High Sensitivity
GDP Growth
High Sensitivity
Liquidity
High Sensitivity
Commodity Prices
Medium Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions

Premium Forecasts

Get AI-powered price predictions, technical analysis, and market forecasts for HOWL.

1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential

Technical Analysis

Based on technical indicators and chart patterns, HOWL shows...

AI Sentiment Analysis

Market sentiment analysis indicates...

Key Statistics
Market Cap$151.7M
Volume991.7K
P/E Ratio-0.63
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
May 3, 2024
Related Securities

PortfolioPilot Analysis

Get AI-powered insights on how HOWL fits into your investment strategy and portfolio diversification.

Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025